Approximately 50–60% of LCH cases have the BRAF V600E mutation, which drives abnormal cell growth, while MAP2K1 mutations are found in an additional 20–30%, especially in BRAF-negative cases [21, 23]. The gene discussed is BRAF; the disease is Langerhans cell histiocytosis.